Compare · BNGO vs MTD
BNGO vs MTD
Side-by-side comparison of Bionano Genomics Inc. (BNGO) and Mettler-Toledo International Inc. (MTD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BNGO and MTD operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
- MTD is the larger of the two at $28.10B, about 1908.6x BNGO ($14.7M).
- Over the past year, BNGO is down 68.6% and MTD is up 9.1% - MTD leads by 77.7 points.
- BNGO has been more active in the news (13 items in the past 4 weeks vs 7 for MTD).
- MTD has more recent analyst coverage (23 ratings vs 5 for BNGO).
- Company
- Bionano Genomics Inc.
- Mettler-Toledo International Inc.
- Price
- $1.25+2.46%
- $1402.84+0.29%
- Market cap
- $14.7M
- $28.10B
- 1M return
- +14.68%
- +4.97%
- 1Y return
- -68.59%
- +9.09%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2018
- 1997
- News (4w)
- 13
- 7
- Recent ratings
- 5
- 23
Bionano Genomics Inc.
Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes. Its Saphyr system includes an instrument, chip consumables, reagents, a suite of data analysis tools, and genome analysis services for researchers to evaluate optical genome mapping data. The company's Bionano prep kits and labeling kits provide the reagents and protocols needed to extract and label ultra-high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. It sells its products for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in the United States and Canada, Europe, the Middle East, India, Africa, China, Japan, South Korea, Singapore, and Australia. Bionano Genomics, Inc. has a procurement and collaboration agreement with NuProbe, Inc. for research and product development in the fields of reproductive health and oncology liquid biopsies. The company was formerly known as BioNano Genomics, Inc. and changed its name to Bionano Genomics, Inc. in July 2018. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
Mettler-Toledo International Inc.
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications. Its laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform. The company's industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, and product inspection systems. Its retail weighing solutions consist of networked scales and software, and stand-alone scales for handling fresh goods, such as meats, vegetables, fruits, and cheeses. The company serves the life science industry, and independent research organizations; food and beverage producers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community. It markets its products through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
Latest BNGO
- Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
- Interim Chief Executive Luderer Albert bought $4,860 worth of shares (4,000 units at $1.22) (SEC Form 4)
- SEC Form 10-Q filed by Bionano Genomics Inc.
- Bionano Genomics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Bionano Reports Second Quarter 2026 Results and Provides a Business Update
- SEC Form 4 filed by Principal Accounting Officer Adamchak Mark
- SEC Form 4 filed by General Counsel Dixon Jonathan V.
- SEC Form 4 filed by Chief Operating Officer Oldakowski Mark
- SEC Form 4 filed by Chief Scientific Officer Hastie Alex Reid
- SEC Form 3 filed by new insider Oldakowski Mark
Latest MTD
- Director Salice Thomas P exercised 417 shares at a strike of $397.95 and sold $600,651 worth of shares (417 units at $1,440.41) (SEC Form 4)
- Director Salice Thomas P exercised 415 shares at a strike of $397.95 and sold $599,517 worth of shares (415 units at $1,444.62) (SEC Form 4)
- Head of Process Analytics Keller Gerry exercised 240 shares at a strike of $720.81 and sold $342,514 worth of shares (240 units at $1,427.14) (SEC Form 4)
- Chief Financial Officer Vadala Shawn exercised 2,240 shares at a strike of $595.31 and sold $3,207,680 worth of shares (2,240 units at $1,432.00) (SEC Form 4)
- SEC Form 3 filed by new insider Shuman-Fabbri Natalia
- Mettler-Toledo International Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Natalia Shuman Joins Mettler Toledo Board of Directors
- SEC Form 10-Q filed by Mettler-Toledo International Inc.
- Mettler-Toledo International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Mettler-Toledo International Inc. Reports Second Quarter 2026 Results